Society for Pediatric Pain Medicine
Better Care for Children in Pain

 

A new qualitative study has been published in The Clinical Journal of Pain, reviewing the perspective of adolescents on prescribing of opioids for acute pain management, exploring opioid decision making and use behaviors. 

The full study can be found here: https://journals.lww.com/clinicalpain/abstract/9900/prescription_opioid_decision_making_and_use.166.aspx

Engaging patients in outpatient pediatric chronic pain programs can be a challenge. A new paper from a group in New Zealand discusses this issue in a new paper. The implications for research and clinical practice are discussed, including improved reporting, patient screening and targeted supports to promote intervention completion.

Read more here: https://www.mdpi.com/2227-9067/11/1/126#

 

A new study by the Department of Anesthesia at Lurie Children’s hospital has published an interesting case series on the use of ultrasound guided occipital nerve blocks for posterior craniotomies.

Follow the link to read the study: https://www.mdpi.com/2227-9067/10/8/1374#

 

 

This Round Table, hosted by the SIG: Creating and Maintaining Pediatric Acute Pain Services, we learn from three experts who will share their clinical experience, research, and protocols for the use of lidocaine infusions for pain at their respective institutions. The goal of this discussion is to review the evidence for the perioperative risks and benefits of lidocaine infusions in pediatric pains, share approaches for the initiation and maintenance of lidocaine infusions in an inpatient setting, and broadly detail indications its use in both acute and chronic pain.

Click here to access the Round Table video.  You will need your SPPM/SPA member login to access the video.

U.S. Food and Drug Administration approved the first test that uses DNA in assessing whether certain individuals may have an elevated risk of developing opioid use disorder (OUD).  The test, AvertD, intended to be used prior to first exposure to oral opioid pain medications in patients being considered for a 4-30 day prescription for the treatment of acute pain.

Follow the link for the full news release: https://www.fda.gov/medical-devices/medical-devices-news-and-events/fda-approves-first-test-help-identify-elevated-risk-developing-opioid-use-disorder